ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 157

Utility of Mailed Reminders for Uveitis Screening Guidelines in Patients with Juvenile Idiopathic Arthritis

Laura Ballenger1 and Kyla Driest2, 1Nationwide Children's Hospital, Columbus, OH, 2Rheumatology, Nationwide Children's Hospital, Columbus, OH

Meeting: 2017 Pediatric Rheumatology Symposium

Keywords: juvenile idiopathic arthritis (JIA), quality improvement and uveitis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Thursday, May 18, 2017

Title: Quality, Health Services and Education Research Poster Session

Session Type: Abstract Submissions

Session Time: 5:30PM-7:00PM

Background/Purpose: Uveitis is a major complication in patients with juvenile idiopathic arthritis (JIA) and can be completely asymptomatic until vision loss develops. In order to prevent ocular complications, it is important to adhere to the recommended screening guidelines which range from every 3 to 12 months depending on JIA subtype, age of onset, duration since diagnosis and ANA status. A previous study within our institution found that barriers to uveitis screening in patients with JIA include difficulty with scheduling appointments and poor knowledge of the screening guidelines. The specific aim of this study was to assess the utility of a mailed reminder letter to patients.

Methods:  Patients at Nationwide Children’s Hospital with JIA who were behind on their screening eye exams were identified through the PR-COIN registry. A reminder letter with information about uveitis and the patient’s specific uveitis screening guidelines was mailed to the patient’s address listed in the EMR. The guardians of those patients or the patients if over 18 years of age receiving letters were called one to two months after the letter was sent and a semi-structured interview was completed. The interview included questions regarding the letter, previous information the family had received about uveitis and ways the family would like to receive reminder notifications in the future.

Results:  44 patients were identified as non-adherent with the screening guidelines. 24 guardians of these patients or patients older than 18 years old were interviewed. 6 of the interviewees (25%) were able to recall receiving the letter in the mail and 4 of these 6 stated that they had read the letter. Of the 4 participants who had read the letter, 2 had been seen by ophthalmology at the time of the phone interview. Despite the low number of patients who remembered receiving the letter, 10 of the 24 interviewed indicated that mail would be the best way to communicate with them. Only 2 of the guardians interviewed (8%) did not know their child’s recommended uveitis screening frequency. Families identified a variety of methods for future communication including mail, email, text message and messages through an online patient portal.

Conclusion:  This qualitative study identified that a small percentage of families recalled receiving a mailed reminder regarding uveitis screening. Some of the families that stated they preferred mail for communication could not recall receiving the reminder letter. Other families identified other preferred methods for communication. Knowledge was less of a barrier than in our previous study. These results will be helpful in developing future tools for sending information and reminders to patients and their families.


Disclosure: L. Ballenger, None; K. Driest, None.

To cite this abstract in AMA style:

Ballenger L, Driest K. Utility of Mailed Reminders for Uveitis Screening Guidelines in Patients with Juvenile Idiopathic Arthritis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 4). https://acrabstracts.org/abstract/utility-of-mailed-reminders-for-uveitis-screening-guidelines-in-patients-with-juvenile-idiopathic-arthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 Pediatric Rheumatology Symposium

ACR Meeting Abstracts - https://acrabstracts.org/abstract/utility-of-mailed-reminders-for-uveitis-screening-guidelines-in-patients-with-juvenile-idiopathic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology